These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 22294726)
1. Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities. Jung HJ; Chen Z; Wang M; Fayad L; Romaguera J; Kwak LW; McCarty N Blood; 2012 Mar; 119(11):2568-78. PubMed ID: 22294726 [TBL] [Abstract][Full Text] [Related]
2. Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications. Pham LV; Tamayo AT; Li C; Bornmann W; Priebe W; Ford RJ Mol Cancer Ther; 2010 Jul; 9(7):2026-36. PubMed ID: 20606045 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma. Yang DT; Young KH; Kahl BS; Markovina S; Miyamoto S Mol Cancer; 2008 May; 7():40. PubMed ID: 18489772 [TBL] [Abstract][Full Text] [Related]
4. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism]. Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142 [TBL] [Abstract][Full Text] [Related]
5. Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma. Jung HJ; Chen Z; Fayad L; Wang M; Romaguera J; Kwak LW; McCarty N Exp Hematol; 2012 Feb; 40(2):107-18.e2. PubMed ID: 22024108 [TBL] [Abstract][Full Text] [Related]
6. The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib. Dasmahapatra G; Patel H; Dent P; Fisher RI; Friedberg J; Grant S Br J Haematol; 2013 Apr; 161(1):43-56. PubMed ID: 23360303 [TBL] [Abstract][Full Text] [Related]
7. Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma. Jung HJ; Chen Z; McCarty N Am J Hematol; 2012 Dec; 87(12):1057-64. PubMed ID: 22965904 [TBL] [Abstract][Full Text] [Related]
8. Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells. Rao R; Nalluri S; Fiskus W; Savoie A; Buckley KM; Ha K; Balusu R; Joshi A; Coothankandaswamy V; Tao J; Sotomayor E; Atadja P; Bhalla KN Clin Cancer Res; 2010 Oct; 16(19):4742-54. PubMed ID: 20647473 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986 [TBL] [Abstract][Full Text] [Related]
10. Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib. Sun B; Shah B; Fiskus W; Qi J; Rajapakshe K; Coarfa C; Li L; Devaraj SG; Sharma S; Zhang L; Wang ML; Saenz DT; Krieger S; Bradner JE; Bhalla KN Blood; 2015 Sep; 126(13):1565-74. PubMed ID: 26254443 [TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma. Jin L; Tabe Y; Kimura S; Zhou Y; Kuroda J; Asou H; Inaba T; Konopleva M; Andreeff M; Miida T Br J Cancer; 2011 Jan; 104(1):91-100. PubMed ID: 21139584 [TBL] [Abstract][Full Text] [Related]
12. The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma. Lyu MA; Pham LV; Sung B; Tamayo AT; Ahn KS; Hittelman WN; Cheung LH; Marks JW; Cho MJ; Ford RJ; Aggarwal BB; Rosenblum MG Biochem Pharmacol; 2012 Aug; 84(4):451-8. PubMed ID: 22687624 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance. Kim A; Seong KM; Kang HJ; Park S; Lee SS Oncotarget; 2015 Nov; 6(35):38225-38. PubMed ID: 26517678 [TBL] [Abstract][Full Text] [Related]
14. P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines. Shirsath NP; Manohar SM; Joshi KS Mol Cancer; 2012 Oct; 11():77. PubMed ID: 23075291 [TBL] [Abstract][Full Text] [Related]
15. Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity. Cagnetta A; Cea M; Calimeri T; Acharya C; Fulciniti M; Tai YT; Hideshima T; Chauhan D; Zhong MY; Patrone F; Nencioni A; Gobbi M; Richardson P; Munshi N; Anderson KC Blood; 2013 Aug; 122(7):1243-55. PubMed ID: 23823317 [TBL] [Abstract][Full Text] [Related]
16. The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78. Roué G; Pérez-Galán P; Mozos A; López-Guerra M; Xargay-Torrent S; Rosich L; Saborit-Villarroya I; Normant E; Campo E; Colomer D Blood; 2011 Jan; 117(4):1270-9. PubMed ID: 21106982 [TBL] [Abstract][Full Text] [Related]
17. Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo. Sun L; Zhang L; Qian J; Yang J; Yi Q; Dong W; Wang M Leuk Res; 2012 Mar; 36(3):363-8. PubMed ID: 22000823 [TBL] [Abstract][Full Text] [Related]
18. Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways. Rizzatti EG; Mora-Jensen H; Weniger MA; Gibellini F; Lee E; Daibata M; Lai R; Wiestner A Leuk Lymphoma; 2008 Apr; 49(4):798-808. PubMed ID: 18398749 [TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386 [TBL] [Abstract][Full Text] [Related]
20. TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy. Zhang H; Chen Z; Miranda RN; Medeiros LJ; McCarty N Cancer Res; 2016 Nov; 76(21):6410-6423. PubMed ID: 27488529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]